| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/27/2006 | US7067255 Hereditary hemochromatosis gene |
| 06/27/2006 | US7067249 with stably expressed short hairpin rnas which degrade hbv pregenomic rna and mRNA; for treatment of cancer, hormonal therapy, immunotherapy, and radiation therapy |
| 06/27/2006 | US7067126 Synthase enzymes having chemokine, angiogenic or angiostsatic activity, used for medical diagnosis and prognosis |
| 06/27/2006 | US7067121 Grafting heart tissue; closure of heart defect |
| 06/27/2006 | US7067120 Cytokine gene modified antigen-presenting cell/tumor cell conjugate, its preparation and use |
| 06/24/2006 | CA2494575A1 Compositions and methods for the treatment of osteoporosis |
| 06/22/2006 | WO2006066158A2 Rnai modulation of mll-af4 and uses thereof |
| 06/22/2006 | WO2006066154A2 Casein kinase 2 antisense therapy |
| 06/22/2006 | WO2006065894A2 Methods for inhibiting stat3 signaling in immune cells |
| 06/22/2006 | WO2006065724A2 Casein kinase 2 antisense therapy |
| 06/22/2006 | WO2006065103A1 Recombiant vector containing mj1 gene and method of site-specific integration using the same |
| 06/22/2006 | WO2006064886A1 Agent for regulating bone formation |
| 06/22/2006 | WO2006064861A1 Function inhibitor of adam10 or adam17 protein and method of screening the same |
| 06/22/2006 | WO2006064813A1 Nucleic acid construct and method of transferring mutation into target region by using the same |
| 06/22/2006 | WO2006064115A1 USE OF NUCLEOTIDE SEQUENCES PREFERABLY INTERACTING WITH THE TRANSCRIPTION COMPLEX PPAR α |
| 06/22/2006 | WO2006063397A1 Determinants of sensitivity to chemotherapeutic agents |
| 06/22/2006 | WO2006029005A3 Promoter substitution for immunoglobulin therapy |
| 06/22/2006 | WO2006015853A3 Use of pax4 in pancreatic cell proliferation |
| 06/22/2006 | WO2006010514A3 Diagnostics and therapeutics for diseases associated with dual specificity mitogen-activated protein kinase kinase 5 (map2k5) |
| 06/22/2006 | WO2006010498A3 Diagnostics and therapeutics for diseases associated with methionine aminopeptidase 2 (metap2) |
| 06/22/2006 | WO2005116210A3 Stat6 inhibiting sirna and shrna for use in the treatment of allergic diseases, pathological changes of the respiratory system and cancer |
| 06/22/2006 | WO2005095953A3 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor type 6 (ccr6) |
| 06/22/2006 | WO2004052276A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 06/22/2006 | US20060136148 Efficient algorithm for PCR testing of blood samples |
| 06/22/2006 | US20060136146 Modulators of ribosomal function and identification thereof |
| 06/22/2006 | US20060135751 Human N-type calcium channel isoform and uses thereof |
| 06/22/2006 | US20060135462 N8- and C8-linked purine bases and structurally related heterocycles as universal nucleosides used for oligonucleotides hybridization |
| 06/22/2006 | US20060135461 Using survivin inhibitor |
| 06/22/2006 | US20060135460 Methods, assays and compositions for treating retinol-related diseases |
| 06/22/2006 | US20060135459 Targeted innate immunity |
| 06/22/2006 | US20060135458 For use as therapeutic agents in viral infections by human and animal viruses and in cancers caused by oncogene viruses |
| 06/22/2006 | US20060135457 Methods for constructing antibiotic resistance free vaccines |
| 06/22/2006 | US20060135456 Methods and compositions for RNA interference |
| 06/22/2006 | US20060135455 Methods and compositions for the inhibition of gene expression |
| 06/22/2006 | US20060135454 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 06/22/2006 | US20060135453 Down-regulation of target-gene with pei/single-stranded oligoribonucleotide complexes |
| 06/22/2006 | US20060135452 Injecting a naked plasmid DNA encoding an angiogenic growth factor such as hepatocyte growth factor, vascular endothelial growth factor, fibroblast growth factor, and nitric oxide synthase into a muscle under conditions of increased pressure inside the muscle, particularly hyperbaric oxygen therapy |
| 06/22/2006 | US20060135451 Vaccine |
| 06/22/2006 | US20060135450 Combinations of antisense oligonucleotides directed against thymidylate synthase mrna and uses thereof |
| 06/22/2006 | US20060135449 A NF- kappa B decoy oligodeoxynucleotide of the sequence GGATTTCCC delivered in a liposome through the carotid artery; antiischemic agents, antitumor agents; analgesics, Alzheimer's Disease; gene transfection |
| 06/22/2006 | US20060135419 Proteins involved in the regulation of energy homeostasis |
| 06/22/2006 | US20060135412 Methods for the treatment of alzheimers disease and compositions therefore |
| 06/22/2006 | US20060134791 Masked targeted expression cassette which expresses a gene product only in the presence of target molecule; neoplasm |
| 06/22/2006 | US20060134787 Methods and compositions for enhancing the efficacy and specificity of single and double blunt-ended siRNA |
| 06/22/2006 | US20060134738 Gene expression inducing fusion protein and method for controlling gene expression Induction |
| 06/22/2006 | US20060134688 Genes overexpressed in prostate disorders as diagnostic and therapeutic targets |
| 06/22/2006 | US20060134668 Methods for treating patients and identifying therapeutics |
| 06/22/2006 | US20060134659 Method for demethylating target methylated region of genome DNA |
| 06/22/2006 | US20060134634 Human gene |
| 06/22/2006 | US20060134220 Vectorization system comprising nanoparticles of homogenous size of at least one polymer and at least one positively charged polysaccharide and method for the preparation thereof |
| 06/22/2006 | US20060134189 siRNA silencing of apolipoprotein B |
| 06/22/2006 | US20060134138 Recombinant influenza viruses for vaccines and gene therapy |
| 06/22/2006 | US20060134129 Anticancer agents; leukemia |
| 06/22/2006 | US20060134123 Comprise the gene of interest and a viral capsid or envelope carrying a member of a specific binding pair, the counterpart of which is not directly associated with the surface of the target cell; used in gene therapy |
| 06/22/2006 | US20060134121 DII4 antagonists, assays, and therapeutic methods thereof |
| 06/22/2006 | US20060134119 Drugs containing galectin 9 |
| 06/22/2006 | US20060134117 Preventives/remedies for cancer |
| 06/22/2006 | US20060134112 Uses of mammalian cytokine; related reagents |
| 06/22/2006 | US20060134110 CD55-Interaction partners and the uses thereof |
| 06/22/2006 | US20060134089 Nitric oxide synthase gene transfer to the atrium for vagal tone increase |
| 06/22/2006 | US20060134086 Targeted enzymes |
| 06/22/2006 | US20060134081 Use of marrow-derived glial progenitor cells as gene delivery vehicles into the central nervous system |
| 06/22/2006 | US20060134080 Administering an inhibitor of vascular endothelial growth factor receptor 1+ bone marrow-derived cells under conditions effective either to inhibit tumor formation or to prevent metastases and comparing the level of vascular endothelial growth factor receptor 1+ bone marrow-derived cells to prior levels |
| 06/22/2006 | US20060134079 Implantable medical devices comprising isolated extracellular matrix |
| 06/22/2006 | US20060134078 Method for culturing neural stem cells using hepatocyte growth factor |
| 06/22/2006 | US20060134077 Electronic commerce system including customized catalog having encoded information |
| 06/22/2006 | US20060134068 Treatment of cancer by simultaneous inhibiton of BRAF and restoration or mimicry of p16INK4A activity |
| 06/22/2006 | US20060134067 Loading of cells with antigens by electroporation |
| 06/22/2006 | US20060134066 Localization of vectors and other agents |
| 06/22/2006 | US20060134065 Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use |
| 06/22/2006 | US20060134048 Topical applying heat shock protein inhibitor |
| 06/22/2006 | CA2591918A1 Cancer-specific spanx-n markers |
| 06/22/2006 | CA2591715A1 Agent for regulating bone formation |
| 06/22/2006 | CA2591544A1 Chimeric vectors |
| 06/21/2006 | EP1672072A2 Cloning and characterisation of the gene flbA of H. pylori; production of flagella-free strains |
| 06/21/2006 | EP1671655A1 Gene therapy for skin diseases using needle free syringe |
| 06/21/2006 | EP1671654A2 Conjugates of hydroxyalkyl starch and an active agent |
| 06/21/2006 | EP1670923A1 Method for mass production of human follicle stimulating hormone |
| 06/21/2006 | EP1670919A2 Method for the production of a cell and/or tissue and/or disease phase specific medicament |
| 06/21/2006 | EP1670908A2 Medical use of tbk-1 or of inhibitors thereof |
| 06/21/2006 | EP1670811A2 Shc proteins as therapeutic targets in proliferative diseases |
| 06/21/2006 | EP1670518A1 Rna interference for the treatment of gain-of-function disorders |
| 06/21/2006 | EP1670517A1 Lentiviral apoe2 gene therapy |
| 06/21/2006 | EP1670508A2 Compositions, methods and kits relating to poxvirus subunit vaccines |
| 06/21/2006 | EP1670497A1 METHODS FOR IDENTIFYING MODULATORS OF PROTEIN KINASE C-EPSILON (PKCϵ) AND METHOD OF TREATMENT OF ABERRANT GLUCOSE METABOLISM ASSOCIATED THEREWITH |
| 06/21/2006 | EP1487274A4 Tissue engineering |
| 06/21/2006 | EP1463797A4 Methods of kidney transplantation utilizing developing nephric tissue |
| 06/21/2006 | EP0934416B1 Feline polynucleotide vaccine formula |
| 06/21/2006 | EP0923600B1 Novel cationic amphiphilic lipids for liposomal gene transfer |
| 06/21/2006 | CN1791679A Gene therapy vectors having reduced immunogenicity based on CD8 alpha-chain |
| 06/21/2006 | CN1791433A DNA vaccines against tumor growth and methods of use thereof |
| 06/21/2006 | CN1789424A Dual target effected chimera recombinant, its construction method and application |
| 06/21/2006 | CN1789416A Human artificial chromosome containing human antibody lambda light chain |
| 06/21/2006 | CN1260361C Inhibition of Ii synthesis |
| 06/21/2006 | CN1260360C Lipid kinase |
| 06/20/2006 | US7064195 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 06/20/2006 | US7064185 Antibody for human Cyr61 |
| 06/20/2006 | US7064111 activating or enhancing T-cell response by locally administering a herpes simplex virus vector with an expressible nucleotide sequence for the soluble costimulatory factor B7-1-Ig or B7-2-Ig, so that the factor is expressed by tumor cells or cells in the immediate area of the tumor |
| 06/20/2006 | US7063971 Phosphodiesterase enzymes |
| 06/20/2006 | US7063961 Having enhanced affinity for the ErbB-3 and ErbB-4 receptors; enhancing survival, proliferation, of differentiation cells. |